{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:06:22Z","timestamp":1751601982199,"version":"3.41.0"},"reference-count":5,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"DOI":"10.2340\/actadv.v105.43629","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:47:20Z","timestamp":1751546840000},"page":"adv43629","source":"Crossref","is-referenced-by-count":0,"title":["Potential Role of Ozenoxacin 1% Cream in the Topical Management of Hidradenitis Suppurativa: A Single-centre Experience (44 patients)"],"prefix":"10.2340","volume":"105","author":[{"given":"Pablo","family":"Fern\u00e1ndez-Crehuet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Diaz-Ceca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Javier","family":"Melgosa Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"117122","doi-asserted-by":"crossref","unstructured":"Zouboulis CC, Bechara FG, Benhadou F, Bettoli V, Bukvi\u0107 Mokos Z, Del Marmol V, et al. European S2k guidelines for hidradenitis suppurativa\/acne inversa part 2: Treatment. J Eur Acad Dermatol Venereol 2025; 39: 899\u2013941.","DOI":"10.1111\/jdv.20472"},{"key":"117123","doi-asserted-by":"crossref","unstructured":"Matusiak \u0141, Bieniek A, Szepietowski JC. Bacteriology of hidradenitis suppurativa: which antibiotics are the treatment of choice? Acta Derm Venereol 2014; 94: 699\u2013702.","DOI":"10.2340\/00015555-1841"},{"key":"117124","doi-asserted-by":"crossref","unstructured":"Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 1983; 22: 325\u2013328.","DOI":"10.1111\/j.1365-4362.1983.tb02150.x"},{"key":"117125","doi-asserted-by":"crossref","unstructured":"Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord 2016; 17: 343\u2013351.","DOI":"10.1007\/s11154-016-9328-5"},{"key":"117126","doi-asserted-by":"crossref","unstructured":"Schachner LA, Lynde CW, Kircik LH, Torrelo A, Hohl D, Kwong P, et al. Treatment of impetigo and antimicrobial resistance. J Drugs Dermatol 2021; 20: 366\u2013372.","DOI":"10.36849\/JDD.5795"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/43629\/50679","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/43629\/50679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:47:25Z","timestamp":1751546845000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/43629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":5,"URL":"https:\/\/doi.org\/10.2340\/actadv.v105.43629","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}